Movement Alert|Medline Inc. Intraday Rise 15.42% in Regular Trading, Q3 Earnings Beat Expectations

Market Focus11-05

On November 5, Medline Inc. rose 15.42% in Regular Trading, trading at $39.33 per share, with turnover of $219 million.

The move followed the company’s latest quarterly results, which exceeded market expectations on both profit and revenue and provided the clearest near-term catalyst for the stock’s strength.

For the quarter ended September 26, adjusted EPS was $0.44, above consensus estimates of $0.35 and $0.34 in market reports. Net sales reached $7.856 billion, ahead of expectations of $7.723 billion and up from $7.12 billion a year earlier. The revenue increase points to continued growth across its medical-surgical products and supply chain solutions businesses, helping drive the sharp advance in the shares.

(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment